Global Autoimmune Disease Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Autoimmune Disease Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2024-2034
The diagnosis of autoimmune diseases depends on the identification of disease-associated clinical symptoms and is associated with the detection of autoantibodies. Clinicians conventionally classify autoimmune diseases as either systemic or organ-specific.
Due to the COVID-19 pandemic, the global Autoimmune Disease Diagnostics market size was US$ 4906.4 million in 2022 and is forecast to a readjusted size of US$ 6801.2 million by 2034 with a CAGR of 4.7% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Analyzers accounting for % of the Autoimmune Disease Diagnostics global market in 2022, is projected to value US$ million by 2034, growing at a revised % CAGR from 2024 to 2034. While Hospitals segment is altered to an % CAGR throughout this forecast period.
In terms of geography, the Americas led the global autoimmune disease diagnostics market and will continue to dominate the market in the coming years. The growing incidence of autoimmune disorders such as RA, SLE, and IBD will aid in the growth of this market. Also, the extensive R&D activities has allowed the launch of novel diagnostic products, which are expected to drive the adoption rates for autoimmune diagnostics in the Americas.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Autoimmune Disease Diagnostics market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Autoimmune Disease Diagnostics market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Autoimmune Disease Diagnostics market. Readers of the report can become informed about current and future trends of the global Autoimmune Disease Diagnostics market and how they will impact market growth during the forecast period.
Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
EUROIMMUN
Inova Diagnostics
Roche Diagnostics
Siemens Healthcare
DiaSorin
ERBA Diagnostics
Euro Diagnostica
Autoimmune Technologies
Avant Diagnostics
Exagen Diagnostics
Gold Standard Diagnostics
HOB Diagnostics
HUMAN Diagnostics
Immco Diagnostics
ImmunArray
Myriad Genetics
Omega Diagnostics
ORGENTEC Diagnostika
Phadia
Protagen
Segment by Type
Analyzers
Assay Kits
Hospitals
Research Laboratories
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Autoimmune Disease Diagnostics in global and regional level.
Chapter 3Detailed analysis of Autoimmune Disease Diagnostics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Autoimmune Disease Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion
Due to the COVID-19 pandemic, the global Autoimmune Disease Diagnostics market size was US$ 4906.4 million in 2022 and is forecast to a readjusted size of US$ 6801.2 million by 2034 with a CAGR of 4.7% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Analyzers accounting for % of the Autoimmune Disease Diagnostics global market in 2022, is projected to value US$ million by 2034, growing at a revised % CAGR from 2024 to 2034. While Hospitals segment is altered to an % CAGR throughout this forecast period.
In terms of geography, the Americas led the global autoimmune disease diagnostics market and will continue to dominate the market in the coming years. The growing incidence of autoimmune disorders such as RA, SLE, and IBD will aid in the growth of this market. Also, the extensive R&D activities has allowed the launch of novel diagnostic products, which are expected to drive the adoption rates for autoimmune diagnostics in the Americas.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Autoimmune Disease Diagnostics market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Autoimmune Disease Diagnostics market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Autoimmune Disease Diagnostics market. Readers of the report can become informed about current and future trends of the global Autoimmune Disease Diagnostics market and how they will impact market growth during the forecast period.
By Company
Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
EUROIMMUN
Inova Diagnostics
Roche Diagnostics
Siemens Healthcare
DiaSorin
ERBA Diagnostics
Euro Diagnostica
Autoimmune Technologies
Avant Diagnostics
Exagen Diagnostics
Gold Standard Diagnostics
HOB Diagnostics
HUMAN Diagnostics
Immco Diagnostics
ImmunArray
Myriad Genetics
Omega Diagnostics
ORGENTEC Diagnostika
Phadia
Protagen
Segment by Type
Analyzers
Assay Kits
Segment by Application
Hospitals
Research Laboratories
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Autoimmune Disease Diagnostics in global and regional level.
Chapter 3Detailed analysis of Autoimmune Disease Diagnostics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Autoimmune Disease Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices